Nisa Investment Advisors LLC Has $202,000 Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Nisa Investment Advisors LLC lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 74.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,561 shares of the pharmacy operator's stock after selling 67,370 shares during the period. Nisa Investment Advisors LLC's holdings in Walgreens Boots Alliance were worth $202,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of WBA. Semanteon Capital Management LP purchased a new stake in shares of Walgreens Boots Alliance in the third quarter valued at approximately $278,000. Frank Rimerman Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance in the third quarter valued at approximately $170,000. MCF Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 117.2% in the third quarter. MCF Advisors LLC now owns 6,792 shares of the pharmacy operator's stock valued at $61,000 after buying an additional 3,665 shares in the last quarter. PFG Investments LLC boosted its stake in shares of Walgreens Boots Alliance by 3.8% in the third quarter. PFG Investments LLC now owns 33,916 shares of the pharmacy operator's stock valued at $304,000 after buying an additional 1,245 shares in the last quarter. Finally, Forsta AP Fonden boosted its stake in shares of Walgreens Boots Alliance by 83.4% in the third quarter. Forsta AP Fonden now owns 385,600 shares of the pharmacy operator's stock valued at $3,455,000 after buying an additional 175,400 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company's stock.

Wall Street Analyst Weigh In

WBA has been the topic of a number of research analyst reports. Bank of America decreased their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an "underperform" rating on the stock in a research report on Wednesday, September 4th. JPMorgan Chase & Co. decreased their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an "overweight" rating on the stock in a research report on Friday, August 30th. Morgan Stanley reduced their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating on the stock in a research report on Friday, October 11th. Evercore ISI upped their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an "in-line" rating in a research report on Wednesday, October 16th. Finally, Barclays upped their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an "underweight" rating in a research report on Wednesday, October 16th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $12.88.

Walgreens Boots Alliance Stock Up 0.4 %

Walgreens Boots Alliance stock traded up $0.04 during mid-day trading on Thursday, hitting $9.27. The company's stock had a trading volume of 19,160,336 shares, compared to its average volume of 17,289,021. The firm's 50 day moving average is $9.18 and its 200 day moving average is $12.30. The company has a market cap of $8.01 billion, a PE ratio of -0.93, a price-to-earnings-growth ratio of 1.22 and a beta of 0.69. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance, Inc. has a 52-week low of $8.22 and a 52-week high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.03. The firm had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company's revenue was up 5.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.67 EPS. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 10.79%. Walgreens Boots Alliance's dividend payout ratio is -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.